RecruitingNCT05607966

A Post-market Observational ORIGIN® CR Clinical Study


Sponsor

Symbios Orthopedie SA

Enrollment

199 participants

Start Date

Jul 10, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The study objective is to evaluate safety and performance of the ORIGIN® CR (cruciate retaining) devices and associated instruments, more precisely to evaluate safety by the proportion of patients requiring a revision (i.e. revision rate) at 1-year post procedure and to evaluate performance by means of a Knee Society Score (KSS) Knee Score at 1 year post procedure and by means of a KSS Function Score also at 1 year post procedure. The hypothesis raised for this study, regarding the scoring, is that patients will experience a marked improvement in the natural feel of the prosthesis during the first year after the surgery, and slightly significant improvement at the following interval of 2 years. The overall patient satisfaction is expected to be improved after 2 years follow-up with ORIGIN® CR.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria5

  • Male and female over 18 years of age
  • Each patient who is willing to give informed consent.
  • Clinically indicated for a total knee replacement
  • Females who are not pregnant and not planning to become pregnant ≤ 12 months. A pregnancy test should be performed for women of childbearing age
  • Geographically stable and willing to return to the implanting site for all follow-up visits at 1 year and 2 years.

Exclusion Criteria16

  • Acute or chronic, local or systemic infection
  • Muscular, ligamental, neurological, psychological or vascular deficits
  • Bone destruction or poor bone quality likely to affect implant stability (requiring a femoral and/or a tibial stem and/or a thick insert)
  • Any concomitant condition likely to affect implant integration or function
  • Allergy or hypersensitivity to any of the materials used
  • For devices in CoCrMo (ISO 5832/4): renal and hepatic impairment
  • Hip Knee Ankle (HKA) angle \< 165° or \> 195°
  • Severe collateral ligaments deficiency (requiring a more constrained prosthesis)
  • Posterior cruciate ligament deficiency
  • Major anatomical deformities
  • Severe flexion contracture or severe recurvatum
  • Revision of a partial or total knee prosthesis
  • Non-extractible material (e.g. screws, plate, intramedullary nail, osteosynthesis material…) which can create a conflict with any component of the prosthesis
  • Distal and/or posterior and/or anterior femoral bone loss which exceeds the femoral component thickness
  • Proximal tibial bone loss which exceeds the tibial component thickness (tibial tray + tibial insert)
  • Bone degradation requiring an anchoring stem for femoral component

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEORIGIN® CR devices

It is planned to include consecutive eligible subjects which will be treated with the ORIGIN® CR devices.


Locations(2)

GZA Ziekenhuizen - campus Sint-Augustinus

Antwerp, Belgium

AZ Voorkempen

Malle, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05607966


Related Trials